Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Hemostatic Markers of Endothelial Dysfunction in the Development of Disease Progression, Thrombotic Complications and Restenosis in Patients With Atherosclerotic Peripheral Artery Disease

NCT04391374 is registered in ClinicalTrials.gov with Ryazan State Medical University as lead sponsor.

NCT NCT04391374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04391374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Hemostatic Markers of Endothelial Dysfunction in the Development of Disease Progression, Thrombotic Complications and Restenosis in Patients With Atherosclerotic Peripheral Artery Disease
Lead sponsor
Ryazan State Medical University
Phase
Observational
Overall status
Completed
Start date
January 31, 2017
Completion date
March 23, 2023
Enrollment
167 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial dysfunction, peripheral artery disease, restenosis of peripheral vascular stent, restenosis, vascular graft